Preventive role of carvedilol in adriamycin-induced cardiomyopathy

BACKGROUND & OBJECTIVES: Adriamycin though considered as an effective anticancer drug, leads to irreversible cardiomyopathy (CMP) and congestive heart failure (CHF). The aim of this study was to determine the protective effect of carvedilol in adriamycin (ADR)-induced cardiomyopathy (CMP) in can...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhorawat, Rajesh, Kumari, Savita, Varma, Subhash C., Rohit, Manoj K., Narula, Nidhi, Suri, Vikas, Malhotra, Pankaj, Jain, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393084/
https://www.ncbi.nlm.nih.gov/pubmed/28361826
http://dx.doi.org/10.4103/ijmr.IJMR_1323_14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393084/
https://www.ncbi.nlm.nih.gov/pubmed/28361826
http://dx.doi.org/10.4103/ijmr.IJMR_1323_14

Ejemplares similares